TB-500
A synthetic version of the active region of thymosin beta-4, commonly discussed for soft-tissue recovery and injury support.
Also referenced as: Thymosin Beta-4 Fragment
Also appears in: Muscle Growth
This name primarily lives in the research market and should not be read like an approved pharmaceutical product.
Primary lane: Recovery. Also surfaces under Muscle Growth for browsing and discovery.
Thymosin Beta-4 Fragment
No FDA label signal · 17 trials · 717 PubMed results
What TB-500 is
TB-500 is a synthetic peptide associated with the active region of thymosin beta-4. It appears frequently in injury-recovery discussions, especially around connective tissue, mobility, and return-to-training conversations.
Why it matters
Alongside BPC-157, TB-500 is one of the most recognizable names in the recovery bucket. Including it makes the recovery category feel much closer to what real users expect to see.
Regulatory context
TB-500 is not an FDA-approved recovery medicine in the United States. It is best understood as a research-market compound with strong community interest and much looser regulatory footing.
Practical reading note
This is another profile where popularity can outrun evidence quality quickly, so category clarity matters more than hype.